Mike Lu is a principal at Vivo Capital, which invests at series a, series b in healthtech, life sciences.
At firms with a similar stage, sector and check size.




One email when Mike's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMike Lu is a principal at Vivo Capital, which invests at series a, series b in healthtech, life sciences.
Vivo Capital has not reported a check size. It invests at series a, series b.
Email [email protected], the firm's inbox for founders, and name Mike in the subject. A warm intro from a founder Vivo Capital backed works better.
Director-Product at YuMe, Inc.; Vice President-Product Management at GREE International, Inc.; Founder at Fusion8, Inc.; President & Co-Chief Executive Officer at Triller Platform Co.; healthcare equity research analyst at Goldman Sachs.
Last updated 2026-10-15. Is this you? Ask for a correction.